MarketWatch provides the latest stock market, financial and business news. View AMGN's stock price, price target, dividend, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat.

View breaking news headlines for AMGN stock from trusted media outlets at MarketBeat. Jun 2, 2020. AMGN | Complete Amgen Inc. stock news by MarketWatch. Amgen Stock News and Research Articles - AMGN : latest news, headlines and research articles. This additional investment reflects Amgen… THOUSAND OAKS, Calif., July 12, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced an additional investment of approximately $421 million in BeiGene's registered direct offering of ordinary shares, which maintains Amgen's current pro rata ownership of BeiGene at approximately 20.3%.

232.84-2.27 (-0.97%) ... News. AMGN updated stock price target summary. Explore commentary on Amgen Inc. and hear what the experts at TheStreet are … View real-time stock prices and stock quotes for a full financial overview. What's going on at Amgen (NASDAQ:AMGN)? Amgen, Inc. stock is up 41.15% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserver’s proprietary ranking system, gives AMGN stock a score …

Amgen Inc. (NASDAQ: AMGN) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Is Amgen stock a buy? From an enhanced free experience to professional stock picking - we have a great plan for you.

Investing.com - Amgen (NASDAQ:AMGN) Stock rose by 3.60% to trade at $238.71 by 15:59 (19:59 GMT) on Friday on the NASDAQ exchange. Find the latest Amgen Inc. (AMGN) stock quote, history, news and other vital information to help you with your stock trading and investing. The stock has traded at …

View today's stock price, news and analysis for Amgen Inc. (AMGN). Shares in Amgen are up 3% year-to-date, and analysts have a cautiously optimistic Moderate Buy consensus on the stock.

Amgen, Inc. stock is up 41.15% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserver’s proprietary ranking system, gives AMGN stock a score of 77 out of a possible 100.. That rank is mainly influenced by a long-term technical score of 92. Amgen Inc. (NASDAQ: AMGN) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. The volume of Amgen shares traded since the start of the session was 3.04M. AMGN | Complete Amgen Inc. stock news by MarketWatch.